Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
27,795,576
-
Total 13F shares
-
26,682,530
-
Share change
-
+1,945,232
-
Total reported value
-
$612,216,265
-
Put/Call ratio
-
71%
-
Price per share
-
$22.95
-
Number of holders
-
116
-
Value change
-
+$44,740,464
-
Number of buys
-
49
-
Number of sells
-
33
Institutional Holders of Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) as of Q3 2018
As of 30 Sep 2018,
Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) was held by
116 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,682,530 shares.
The largest 10 holders included
ORACLE INVESTMENT MANAGEMENT INC, CREDIT SUISSE AG/, Birchview Capital, LP, BlackRock Inc., Vanguard Group Inc, CANNELL PETER B & CO INC, BLAIR WILLIAM & CO/IL, AMUNDI PIONEER ASSET MANAGEMENT INC, ArrowMark Colorado Holdings LLC, and Chicago Capital, LLC.
This page lists
116
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.